These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Endeavors to eradicate measles in the Americas]. de Quadros CA Rev Esp Salud Publica; 1999; 73(5):589-96. PubMed ID: 10650749 [No Abstract] [Full Text] [Related]
24. [Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination]. Colomer Pache M; Arnedo Pena A Med Clin (Barc); 1988 Nov; 91(17):649-52. PubMed ID: 3230970 [No Abstract] [Full Text] [Related]
25. [Measles in Chile]. Serra I; Romero MI Rev Med Chil; 1990 Feb; 118(2):214-24. PubMed ID: 2152725 [TBL] [Abstract][Full Text] [Related]
26. [The impact of immunization against measles on epidemiology of measles in Poland]. Janaszek W Przegl Epidemiol; 1998; 52(4):413-25. PubMed ID: 10321085 [TBL] [Abstract][Full Text] [Related]
27. The control of measles in New York City. Imperato PJ; Pincus L; Hwa CL; Chaves AD Bull N Y Acad Med; 1974 May; 50(5):602-19. PubMed ID: 4595488 [No Abstract] [Full Text] [Related]
29. Africa's largest measles vaccination campaign could reduce childhood mortality by 20%. Wanyama C Bull World Health Organ; 2002; 80(12):989. PubMed ID: 12571734 [No Abstract] [Full Text] [Related]
30. Measles infection following immunization: a report on forty-nine cases in Lagos, NIgeria. Williams GA Afr J Med Sci; 1971 Apr; 2(2):159-63. PubMed ID: 5111615 [No Abstract] [Full Text] [Related]
32. [Epidemiologic situation of measles before the introduction of a vaccination against measles and after 7 years of its use]. Rozwoda J Przegl Epidemiol; 1985; 39(2):273-9. PubMed ID: 4081083 [No Abstract] [Full Text] [Related]
33. Guidelines for measles control in Canada. Can Dis Wkly Rep; 1991 Feb; 17(7):35-40. PubMed ID: 2029737 [No Abstract] [Full Text] [Related]
35. Re-emergence of measles. Lamabadusuriya SP; Senanayake M Ceylon Med J; 1999 Dec; 44(4):185-6. PubMed ID: 10895275 [No Abstract] [Full Text] [Related]
36. A new look at measles. Adcock LM; Bissey JD; Feigin RD Infect Dis Clin North Am; 1992 Mar; 6(1):133-48. PubMed ID: 1578113 [TBL] [Abstract][Full Text] [Related]
37. [Basis for the need for mass revaccination against measles and results of conducting it]. Rykushin IuP; Deshevoĭ SE Tr Inst Im Pastera; 1992; 67():96-102. PubMed ID: 8539773 [No Abstract] [Full Text] [Related]
38. Measles in the United States. Stat Bull Metropol Life Insur Co; 1974 Apr; 55():6-10. PubMed ID: 4829028 [No Abstract] [Full Text] [Related]
39. [Epidemiological characteristics of measles in mass vaccine prophylaxis and the prospects for its eradication]. Smorodintsev AA; Rykushin IuP; Smorodintsev AlA Tr Inst Im Pastera; 1982; 57():10-6. PubMed ID: 6221441 [No Abstract] [Full Text] [Related]
40. [Importance of measles in Czechoslovakia]. Procházka J; Mílek E; Grantová H Cesk Pediatr; 1968 Apr; 23(4):289-92. PubMed ID: 5676094 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]